Chair tenure extension

Summary by AI ^BETAClose X

SThree plc has announced an extension of its Chair, James Bilefield's, tenure by seven months until April 2027, following shareholder consultation. This extension is intended to allow Mr. Bilefield to oversee the conclusion of the search for a permanent Chief Financial Officer before focusing on Chair succession. Mr. Bilefield, who joined the board in October 2017 and became Chair in April 2018, will have his nine-year term conclude in September 2026, with the extension ensuring continuity during a critical period for the company.

Disclaimer*

SThree plc

15 June 2026

SThree - Chair tenure extension

SThree plc, the global STEM workforce consultancy, announces that, after consultation with shareholders, the Board is extending James Bilefield's tenure as Chair for a seven-month period, until April 2027. This extension allows James, as Chair of the Nomination Committee, to conclude the search for a permanent Chief Financial Officer, before the Nomination Committee turns its focus to Chair succession.

James was appointed to the Board in October 2017, becoming Chair in April 2018. James' nine-year term will therefore conclude in September 2026. The Nomination Committee recommended to the Board a short, time-bound extension for James to remain as Chair until the conclusion of the Company's annual general meeting in April 2027.

Imogen Joss, Senior Independent Non-Executive Director, commented:

"I am delighted that James has agreed to this short extension of tenure. He has been a strong independent director throughout his time at SThree and a valued source of support to the Executive Team. We are very grateful for his continued contribution and believe this extension is in the best interests of the Company."

Enquiries:

SThree plc
Timo Lehne, CEO Damian Fehrenberg, Interim CFO Charlie Hildesley, Investor Relations Manager	via Alma
Alma Strategic Communications	+44 20 3405 0205
Rebecca Sanders-Hewett Hilary Buchanan Sam Modlin Rose Docherty	SThree@almastrategic.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END